arrow
R

Rebeca Sanz-Pamplona

clinical university hospital lozano blesa and aragon health research institute
H指数:32
被引数:3,275

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer
2024-06-200
PRE
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

dsRNAi介导的PIAS2beta沉默通过有丝分裂灾难特异性杀死间变性癌

2024-05-142
OAAI
Germline genetic regulation of the colorectal tumor immune microenvironment

结直肠肿瘤免疫微环境的种系基因调控

2024-04-251
OAAI
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
2024-03-213
OAAI
CAR Immunotherapy for the treatment of infectious diseases: a systematic review

CAR免疫疗法治疗感染性疾病的系统评价

2024-01-309
OAAI
Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer

HLA I类和II类基因座的杂合子优势和降低结直肠癌的风险

2023-10-244
OAAI
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
2023-03-164
OA
MmCMS: mouse models' consensus molecular subtypes of colorectal cancer
2023-01-3010
OA
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer
2022-11-143
OAAI
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA
2022-07-0914
OAAI
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, INFα, and IL-1β
2022-06-3028
OA
Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo
2022-06-0711
OAAI